Anwar A. Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anwar A. Hussain has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Abeer M. Al-Ghananeem
Division of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, USA
1 shared publicationAdnan Dakkuri
College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307‐2740
1 shared publicationAnsam A. Al‐Bayatti
Biochemistry Department, College of Medicine, University of Baghdad, Baghdad, Iraq
1 shared publicationAshraf A. Traboulsi
University of Kentucky
1 shared publicationJanan Jona
University of Kentucky College of Pharmacy
1 shared publicationKazuhiro Okochi
Takeda Chemical Industries, Osaka, Japan
1 shared publication
Latest Publications
- 1 March 2002
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 3 (1) , 40-47
Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs
The utility of the nasal route for the systemic delivery of 17β-estradiol was studied using watersoluble prodrugs of 17β-estradiol. This delivery method was examined to determine if it will result in preferential delivery to the brain. Several alkyl prodrugs of 17β-estradiol were prepared and their physicochemical properties were determined. In vitro hydrolysis rate constants in buffer, rat plasma, and rat brain homogenate were determined by high-performance liquid chromatography. In vivo nasal experiments were carried out on rats. Levels of 17β-estradiol in plasma and cerebral spinal fluid (CSF) were determined with radioimunoassay using a gamma counter. The study revealed that the aqueous solubilities of the prodrugs were several orders of magnitude greater than 17β-estradiol with relatively fast in vitro conversion in rat plasma. Absorption was fast following nasal delivery of the prodrugs with high bioavailability. CSF 17β-estradiol concentration was higher following nasal delivery of the prodrugs compared to an equivalent intravenous dose. It was determined that water-soluble prodrugs of 17β-estradiol can be administered nasally. These prodrugs are capable of producing high levels of estradiol in the CSF and as a result may have a significant value in the treatment of Alzheimer's disease.
- 1 March 2002
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 3 (1) , 40-47
Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs
The utility of the nasal route for the systemic delivery of 17β-estradiol was studied using watersoluble prodrugs of 17β-estradiol. This delivery method was examined to determine if it will result in preferential delivery to the brain. Several alkyl prodrugs of 17β-estradiol were prepared and their physicochemical properties were determined. In vitro hydrolysis rate constants in buffer, rat plasma, and rat brain homogenate were determined by high-performance liquid chromatography. In vivo nasal experiments were carried out on rats. Levels of 17β-estradiol in plasma and cerebral spinal fluid (CSF) were determined with radioimunoassay using a gamma counter. The study revealed that the aqueous solubilities of the prodrugs were several orders of magnitude greater than 17β-estradiol with relatively fast in vitro conversion in rat plasma. Absorption was fast following nasal delivery of the prodrugs with high bioavailability. CSF 17β-estradiol concentration was higher following nasal delivery of the prodrugs compared to an equivalent intravenous dose. It was determined that water-soluble prodrugs of 17β-estradiol can be administered nasally. These prodrugs are capable of producing high levels of estradiol in the CSF and as a result may have a significant value in the treatment of Alzheimer's disease.
- 1 March 2002
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (3) , 785-789
Testosterone 17β‐N,N‐Dimethylglycinate Hydrochloride: A Prodrug with a Potential for Nasal Delivery of Testosterone
- 1 March 2002
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (3) , 785-789
Testosterone 17β‐N,N‐Dimethylglycinate Hydrochloride: A Prodrug with a Potential for Nasal Delivery of Testosterone
- Open Access
- 1 September 2000
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 1 (3) , 1-4
Competitive inhibitory effect of external nucleophile concentration on intramolecular O- to N-acylation in O-acetylsalicylamide
- 1 September 2000
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 1 (3) , 1-4
Open AccessCompetitive inhibitory effect of external nucleophile concentration on intramolecular O- to N-acylation in O-acetylsalicylamide